Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas.
This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr–San Juan–Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March...
| Published in: | American Journal of Public Health Vol. 112; no. 9; pp. 1269 - 1273 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Published: |
American Public Health Association
Sep2022
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=158508215&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 158508215 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00900036 APH jtl: American Journal of Public Health issn: 00900036 maglogo: N pubinfo: dt: Sep2022 vid: 112 iid: 9 pid: 44 pub: American Public Health Association artinfo: ui: 158508215 10.2105/ajph.2022.306970 ppf: 1269 ppct: 4 formats: tig: atl: Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas. aug: au: Rodriguez, Ana M. Do, Thuy Quynh N. Jibaja-Weiss, Maria L. Chen, Lu Schmeler, Kathleen M. Montealegre, Jane R. Kuo, Yong-Fang su: Texas Immunization Middle schools COVID-19 pandemic Medical protocols Human papillomavirus vaccines Papillomavirus diseases sug: subj: Immunization Middle schools COVID-19 pandemic Texas Elementary and Secondary Schools Medical protocols Human papillomavirus vaccines Papillomavirus diseases ab: This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr–San Juan–Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (Am J Public Health. 2022;112(9):1269–1272. https://doi.org/10.2105/AJPH.2022.306970) pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|